The Latest in Critical Care, 10/23/23 (Issue #17)
PulmCCM
OCTOBER 23, 2023
Read in JAMA Does Paxlovid Improve Covid-19 Outcomes in the Omicron Era? Even people with COPD or asthma under age 50 did not benefit from Paxlovid, in that analysis. absolute risk reduction in the composite outcome among the immunocompromised or those with significant medical conditions. Paxlovid was associated with about a 1.5-2.5%
Let's personalize your content